Elucid | Visualize Lesion-level Plaque Composition
Developed in partnership with world-renowned cardiovascular pathologists, ground truth histology serves as the basis for training Elucid’s powerful algorithm to objectively quantify vessel structure …
Elucid Receives U.S. 510 (k) Clearance of PlaqueIQ™ Image Analysis ...
Oct 1, 2024 · Elucid is a Boston-based AI medical technology company dedicated to developing technology designed to provide physicians with a more precise view of atherosclerosis (coronary …
News - Elucid
Jul 17, 2025 · BOSTON – March 3, 2025 – Elucid, an AI medical technology company focused on providing physicians with a more precise view of atherosclerosis to drive patient-specific therapeutic …
Elucid Raises $80 Million in Series C Round Led by Elevage Medical ...
Nov 9, 2023 · Elucid is a Boston-based medical technology company dedicated to bringing precision patient care, as currently practiced in oncology, to cardiology. Its AI-powered imaging analysis …
Elucid Announces Favorable Medicare Coverage of AI Coronary Plaque ...
Oct 15, 2024 · Elucid is a Boston-based AI medical technology company dedicated to developing technology designed to provide physicians with a more precise view of atherosclerosis (coronary …
Elucid Names Kelly Huang as CEO
Elucid is a Boston-based AI medical technology company dedicated to developing technology designed to help physicians better understand the root cause of cardiovascular disease.
Elucid Adds Clinical and Commercial Leadership Ahead of PlaqueIQ ...
Mar 3, 2025 · Elucid is a Boston-based AI medical technology company dedicated to developing technology designed to provide physicians with a more precise view of atherosclerosis (coronary …
Elucid Presents Data Demonstrating Its AI Software Can Uniquely ...
Elucid is a Boston-based medical technology company using uniquely interpretable and validated AI to provide physicians with a cost-effective means to optimize treatment decisions for patients with …
Elucid Applauds CMS Inclusion of Coronary CTA with Plaque Analysis in ...
Elucid is a Boston-based AI medical technology company dedicated to developing technology designed to provide physicians with a more precise view of atherosclerosis (coronary plaque buildup), the root …
Press Releases | Elucid
Aug 11, 2025 · BOSTON – March 3, 2025 – Elucid, an AI medical technology company focused on providing physicians with a more precise view of atherosclerosis to drive patient-specific therapeutic …